Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study

Abstract

PATH, GlaxoSmithKline Biologicals SA. ClinicalTrials.gov identifier NCT01262872.